Alta Vista would like to clarify the new terms for its purchase of 90% of RedeCan Pharm, one of twenty Marijuana for Medical Purposes Regulations cultivation and sales licenses. The amended terms of the acquisition consider the purchase of a 90% interest in RedeCan with no royalty by paying to the owner of RedeCan $8,000,000 and issuing a total of [...]
Alta Vista Ventures and RedeCan Pharm have agreed to remove the royalty that had been previously considered under the original Letter of Intent. There is now no overriding royalty to be paid. The amended terms of the acquisition consider the purchase of a 90% interest in RedeCan by paying to the owner of RedeCan $8,000,000 (Eight Million) and [...]
Alta Vista Ventures has signed an engagement letter with Jacob Capital Managementfor the purposes of completing the acquisition of RedeCan Pharm and expanding its operations. Redecan Pharm is one of Canada’s 20 MMPR cultivation and sales licenses. “We are very familiar with RedeCan Pharm and the great job the founders have done in growing the [...]
Alta Vista Ventures announces that Mr. George Smitherman has joined its Board of Directors and that Mr. Kim Derry has joined the Company as Senior Advisor – Safety and Security. Mr. Smitherman had a long successful political career until 2010 when he returned to his pre politics roots as an entrepreneur. He is the founder of three companies and is [...]
Alta Vista Ventures is pleased to announce that the Company has added Mr. Rob McPherson as a Senior Advisor. Mr. McPherson brings with him over 25 years of experience in strategic planning, product development, marketing, and corporate management. “We are very fortunate to bring on a person of Rob’s calibre to Alta Vista. He will be integral in [...]
lta Vista is pleased to provide additional information on RedeCan Pharm, one of Canada’s 20 MMPR cultivation and sales licenses that Alta Vista has the right to purchase a 100% interest in (see news release dated November 27th, 2015). Redecan Pharm is located in the heart of the Niagara peninsula in Southern Ontario and currently utilizes 15,000 [...]
Alta Vista Ventures is pleased to announce that it has signed a Letter of Intent to purchase a 100% undivided interest in RedeCan Pharm, one of Canada’s 19 MMPR cultivation and sales licenses. “The completion of this transaction puts Alta Vista in a select group of public companies”, stated Ian Foreman, president of Alta Vista, “as there are only a [...]
Alta Vista Ventures is pleased to announce that it has filed all required paperwork, issued 3,330,000 units at a price of $0.05 per Unit for total proceeds of $166,500 as tranche 2 of its financing. The financing is formally closed with total proceeds of $247,500. All securities issued pursuant to tranche 2 of the placement are subject to a hold [...]
Alta Vista is pleased to announce that it has received subscription agreements for an additional $166,500 or for 3,330,000 units at a price of $0.05 per Unit as tranche two of its financing. The Company has now closed the financing and will not accept any additional subscription agreements. Each Unit consists of one previously unissued common share [...]
Alta Vista is pleased to announce that it has filed all required paperwork, issued 1,620,000 units at a price of $0.05 per Unit for total proceeds of $81,000 and formally closed tranche one of its ongoing financing. Each Unit consists of one previously unissued common share and one transferable purchase warrant (a “Warrant) of the Company. Each [...]
Alta Vista is pleased to announce that it has received subscription agreements for a total of $81,000 or for 1,620,000 units at a price of $0.05 per Unit and has closed tranche one of its ongoing financing. Each Unit consists of one previously unissued common share and one transferable purchase warrant of the Company. Each Warrant will entitle the [...]
Alta Vista Ventures is pleased to announce that it has added Dr. Bob Melamede to its Advisory Board. Dr. Melamede earned his Ph.D. in Molecular Biochemistry in 1980. In 2013 he retired from University of Colorado at Colorado Springs as a tenured Associate Professor. He is very well known as a leader in the advancement of medical cannabis [...]
